(Mary Ann Liebert, Inc./Genetic Engineering News) In a simulated study, exposure to and maximum blood concentrations of two selective serotonin reuptake inhibitors (SSRIs) -- commonly used to treat anxiety and depression in adolescents -- differed depending on whether the teens modeled were poor, normal, rapid, or ultra-rapid metabolizers of the SSRIs.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2OXTDMA
No comments:
Post a Comment